Meningioma: Is There an Association with Human Leukocyte Antigens?

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 12, 2003, Pages 1438-1442

  Machulla, Helmut K G ^a   Steinborn, Frank ^a,b   Tschigrjai, Michail ^a   Langner, Jürgen ^a   Rainov, Nikolai G ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Krankenhaus St Elisabeth und St Barbara   (Germany)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ANTIGEN RECOGNITION; ARTICLE; CAUCASIAN; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION; HAPLOTYPE; HLA TYPING; HUMAN; IMMUNOSURVEILLANCE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SYMPTOMATOLOGY; TUMOR CELL DESTRUCTION;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA ANTIGENS; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0346732944     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Preston-Martin, S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology, 8: 283-295, 1989.
2. Sutherland, G., Florell, R., Louw, D., Choi, N., and Sima, A. Epidemiology of primary intracranial neoplasms in Manitoba, Canada. Can J. Neurol. Sci., 14: 586-592, 1987.
3. Kleihues, P., Burger, P. C., and Scheithauer, B. W. The new WHO classification of brain tumours. Brain Pathol., 3: 255-268, 1993.
4. Phillips, L., Koepsell, T., van Belle, G., Kukull, W., Gehrels, J., and Longstreth, W. J. History of head trauma and risk of intracranial meningioma: population-based case-control study. Neurology, 58: 1849-1852, 2002.
5. Kros, J., and Wolbers, J. Meningiomas: prognostic relevance of histopathologic and genetic markers. Ned Tijdschr Geneeskd, 145: 2160-2165, 2001.
6. Torp, S., Lindboe, C., Granli, U., Moen, T., and Nordtomme, T. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas. Clin. Neuropathol., 20: 190-195, 2001.
7. Kamei, Y., Watanabe, M., Nakayama, T., Kanamaru, K., Waga, S., and Shiraishi, T. Prognostic significance of p53 and p21WAF1/CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas. J. Neurooncol., 46: 205-213, 2000.
8. Bateman, A. C., and Howell, W. M. Human leukocyte antigens and cancer: is it in our genes? J. Pathol., 188: 231-236, 1999.
9. Modica, M., Colucci, A., Condore, G., and Caruso, C. The HLA-B8, DR3 haplotype and immune response in healthy subjects. Immol. Inf. Dis., 3: 119-127, 1993.
10. Caruso, C., Candore, G., Modica, M., Bonanno, C., Sireci, G., Dieli, F., and Salemo, A. Major histocompatibility complex regulation of cytokine production. J. Interferon. Cytokine Res., 16: 983-988, 1996.
11. Petrovsky, N., and Harrison, L. C. HLA class II-associated polymorphism of interferon-γ production. Implications for HLA-disease association. Hum. Immunol., 53: 12-16, 1997.
12. Cortes, J., Fayad, L., Kantarjian, H., O'Brien, S., Lee, M. S., and Talpaz, M. Association of HLA phenotype and response to interferon-α in patients with chronic myelogenous leukemia. Leukemia (Baltimore), 12: 455-462, 1998.
13. Tuttle, T. M., Anderson, B. W., Thompson, W. E., Lee, J. E., Sahin, A., Smith, T. L., Grabstein, K. H., Wharton, J. T., Ioannides, C. G., and Murray, J. L. Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients. Clin. Cancer Res., 4: 2015-2024, 1998.
14. Lee, J. E., Abdalla, J., Porter, G. A., Bradford, L., Grimm, E. A., Reveille, J. D., Mansfield, P. F., Gershenwald, J. E., and Ross, M. I. Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon γ levels and disease recurrence in melanoma patients. Ann. Surg. Oncol., 9: 587-593, 2002.
15. Tang, K. F., Chan, S. H., Loh, K. S., Chong, S. M., Wang, D., Yeoh, K. H., and Hu, H. Increased production of interferon-γ by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: indicative of an activated status. Cancer Lett., 140: 93-98, 1999.
16. Lechler, R. HLA and Disease. London, Boston, San Diego, New York, Sydney, Tokyo: Academic Press Limited, 1994.
17. Svejgaard, A., and Ryder, L. P. HLA and disease associations: Detecting the strongest association. Tiss. Antigens, 43: 18-27, 1994.
18. Burt, R. D., Vaughan, T. L., McKnight, B., Davis, S., Beckmann, A. M., Smith, A. G., Nisperos, B., Swanson, G. M., and Berwick, M. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol. Biomark. Prev., 5: 879-887, 1996.
19. Hildesheim, A., Schiffman, M., Scott, D. R., Marti, D., Kissner, T., Sherman, M. E., Glass, A. G., Manos, M. M., Lorincz, A. T., Kurman, R. J., Buckland, J., Rush, B. B., and Carrington, M. Human leukocyte antigen class I/ II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol. Biomark. Prev., 7: 1035-1041, 1998.
20. Wagner, U., Kalthäuser, S., Sauer, H., Arnold, S., Seidel, W., Hantzschel, H., Kalden, J. R., and Wassmuth, R. HLA markers and prediction of clinical course on outcome in rheumatoid arthritis. Arthrit. Rheumatism, 40: 341-351, 1997.
21. Schlosstein, L., Terasaki, P. I., Bluestone, R., and Pearson, C. M. High association of an HL-A antigen, W 27, with ankylosing spondylitis. N. Engl. J. Med., 288: 704-706, 1973.
22. Tang, W. M., Pulido, J. S., Eckels, D. D., Han, D. P., Mieler, W. F., and Pierce, K. The association of HLA-DR15 and intermediate uveitis. Am. J. Ophthalmol., 123: 70-75, 1997.
23. Sanjeevi, C. B., Hjelmstrom, P., Hallmans, G., Wiklund, F., Lenner, P., Angstrom, T., Dillner, J., and Lernmark, A. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int. J. Cancer, 68: 409-414, 1996.
24. Coraddu, F., Sawcer, S., Feakes, R., Chataway, J., Broadley, S., Jones, H. B., Clayton, D., Gray, J., Smith, S., Taylor, C., Goodfellow, P. N., and Compston, A. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics, 2: 24-33, 1998.
25. Juji, T., Satake, M., Honda, Y., and Doi, Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tiss. Antigens, 24: 316-319, 1984.
26. Takai, N., Yoshida, S., Hara, N., Saito, T., Kamoya, K., and Tanaka, R. Investigation of HLA in patients with glioma. No To Shinkei, 38: 741-745, 1986.
27. Nitta, T., Ebato, M., and Sato, K. Association of malignant glioma with the human leukocyte antigen, HLA-A24(9). Neurosurg. Rev., 17: 211-215, 1994.
28. De Moerloose, P., Jeannet, M., Martin-Achard, A., de Tribolet, N., Seiler, R., and Guanella, N. HLA and glioma. Tiss. Antigens, 12: 146-148, 1978.
29. Machulla, H. K., Steinbom, F., Schaaf, A., Heidecke, V., and Rainov, N. G. Brain glioma and human leukocyte antigens (HLA) is there an association. J. Neuro-Oncol., 52: 253-261, 2001.
30. Ferrante, P., Pagani, E., Guerini, F., Tarantini, L., Borghi, E., Omodeo-Zorini, E., Monga, G., Car, P., and Boldorini, R. Evidence of JC virus and HLA involvement in the pathogenesis of human brain tumors. Neuro-Oncology, 31: 2002.
31. Herrlinger, U., Müller, C., Korfel, A., Thiel, E., and Weller, M. Primary CNS lymphoma: Association with HLA alleles? Neuro-Oncology, 45: 2002.
32. Terasaki, P. I., and McClelland, J. D. Microdroplet assay of human serum cytotoxins. Nature (Lond.), 204: 998-1000, 1964.
33. Olerup, O., and Zetterquist, H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tiss. Antigens, 39: 225-235, 1992.
34. Dyer, P., and Warrens, A. Design and interpretation of studies of the major histocompatibility complex in disease. In: R. Lechler (ed.), HLA and Disease, pp. 93-122. London. Boston. San Diego, New York, Sydney, Tokyo: Academic Press Limited, 1994.
35. Agresti, A. A survey of exact inference for contingency tables. Statistical Science, 7: 131-177, 1992.
36. Rosner, B. Fundamentals of Biostatistics. Boston: PWS Publishers, 1986.
37. Mattiuz, P. L., Ihde, D., Piazza, A., Cepellini, R., and Bodmer, W. F. New approaches to the population genetic and segregation analysis of the HL-A system. In: P. I. Terasaki (ed.), Histocompatibility Testing 1970, p. 193. Copenhagen, Denmark: Munksgaard, 1970.
38. Baur, M. P., and Danilovs, J. A. Population analysis of HLA-A, B, C, DR and other genetic markers. In: P. I. Terasaki (ed.), Histocompatibility Testing 1980, p. 955. Copenhagen, Denmark: Munksgaard, 1980.
39. Tiwari, J. L., and Terasaki, P. I. HLA and Disease Associations, p. 20. New York: Springer, 1985.
40. Chan, S. H., Chew, C. T., Prasad, U., Wee, G. B., Srinivasan, N., and Kunaratnam, N. HLA and nasopharyngeal carcinoma in Malays. Br. J. Cancer, 51: 389-392, 1985.
41. Chatzipetrou, M. A., Tarassi, K. E., Konstadoulakis. M. M., Pappas, H. E., Zafirellis, K. D., Athanassiades, T. E., Papadopoulos, S. A., Panousopoulos, D. G., Golematis, B. C., and Papasteriades, C. A. Human leukocyte antigens as genetic markers in colorectal carcinoma. Dis. Colon Rectum., 42: 66-70, 1999.
42. Sridama, V., Hara, Y., Fauchet, R., and DeGroot, L. J. Association of differentiated thyroid carcinoma with HLA-DR7. Cancer (Phila.), 56: 1086-1088, 1985.
43. Lu, C. C., Chen, J. C., Jin, Y. T., Yang, H. B., Chan, S. H., and Tsai, S. T. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int. J. Cancer, 103: 745-751, 2003.
44. Romano, P, J., Bartholomew, M., Smith, P. J., Kloszewski, F., Stryker, J., Houck, J., and Vesell, E. S. HLA antigens influence resistance to lung carcinoma. Hum. Immunol., 31: 236-240, 1991.
45. Krul, E. J., Schipper, R. F., Schreuder, G. M., Fleuren, G. J., Kenter, G. G., and Melief, C. J. HLA and susceptibility to cervical neoplasia. Hum. Immunol., 60: 337-342, 1999.
46. Wang, S., Hildesheim, A., Gao, X., Schiffman, M., Herrero, R., Bratti, M., Sherman, M., Barnes, W., Greenberg, M., McGowan, L., Mortel, R., Schwartz, P., Zaino, R., Glass, A., Burk, R., Karacki, P., and Carrington, M. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J. Infect. Dis., 186: 598-605, 2002.